| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |